Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-20
    E.g., 2018-09-20

Archive Search

Pages

20 results
11:50 AM, May 01, 2017  |  BC Extra | Company News

Shire, Parion in deal for ENaC inhibitor for dry eye

Parion Sciences Inc. (Durham, N.C.) granted Shire plc (LSE:SHP; NASDAQ:SHPG) exclusive, worldwide rights to P-321 ophthalmic solution, an epithelial sodium channel (ENaC) inhibitor in development to treat dry eye disease. Parion received $20 million up front...
6:01 PM, Jul 11, 2016  |  BC Extra | Company News

FDA approves Shire's Xiidra

complete response letter. Xiidra is an eye drop formulation of a small molecule integrin beta(2) (LFA-1
6:14 PM, Jan 25, 2016  |  BC Extra | Company News

Shire resubmits lifitegrast NDA

SARcode Bioscience Inc. Lifitegrast is an eye drop formulation of a small molecule integrin beta(2) (LFA-1
6:27 PM, Oct 19, 2015  |  BC Extra | Company News

FDA wants another lifitegrast trial from Shire

16, 2014) . Shire gained the eye drop formulation of a small molecule integrin beta(2) (LFA-1
6:08 PM, Apr 09, 2015  |  BC Extra | Top Story

Priority Review erases Shire's losses on trial miss

2014) . The company gained the eye drop formulation of a small molecule integrin beta(2) (LFA-1
6:32 PM, Feb 12, 2015  |  BC Extra | Company News

Shire's firepower

amphetamine , and Lifitegrast , an eye drop formulation of a small molecule integrin beta(2) (LFA-1
7:24 PM, Jan 12, 2015  |  BC Extra | Top Story

NPS acquisition could push Shire past 2020 goal

NDA to FDA for lifitegrast, an eye drop formulation of a small molecule integrin beta(2) (LFA-1
6:02 PM, Jun 23, 2014  |  BC Extra | Company News

Shire targeting $10B in sales by 2020

an NDA to FDA for the eye drop formulation of a small molecule integrin beta(2) (LFA-1
5:18 PM, May 16, 2014  |  BC Extra | Company News

Shire forms ophthalmic unit, to submit lifitegrast NDA

scores. Shire gained lifitegrast -- an eye drop formulation of a small molecule integrin beta(2) (LFA-1

Pages